Summary results
| Version 1 protocol (n=5) | Version 2 protocol (n=18) | Total (n=23) | |
| No. (%) or mean±SD | No. (%) or mean±SD | No. (%) or mean±SD | |
| Reduction successful* | 3 (60%) | 18 (100%) | 21 (91%) |
| Adverse events | 0 (0%) | 0 (0%) | 0 (0%) |
| Max Cpt (µg/mL)† | 2±0 | 2.5±0.6 | 2.4±0.6 |
| Time to OAA/S 3 (min)‡§ | 13±1.4 | 26.1±8.4 | 24.7±9 |
| Time to reduction (min)¶* | 14.5±3.5 | 28.9±9 | 27.5±9.6 |
*One patient self-reduced at OAA/S 4.
†One patient did not have max Cpt documented.
‡Four patients did not have time to OAA/S 3 documented.
§Two patients did not achieve OAA/S 3.
¶Three patients did not have time to reduction documented.